Recent developments in litigation surrounding the herbicide Paraquat have highlighted ongoing challenges for plaintiffs in establishing expert testimony. In a recent judgment, another judge has decided against accepting the testimony from the expert witness representing Paraquat plaintiffs. This is part of a series of decisions reflecting a growing skepticism among the judiciary with respect to the claims made by the plaintiffs’ experts. For further details, more information is available here.
In a separate update, ClaimClam, a known class action filer, is reportedly shifting its strategy away from pursuing settlements and avoiding potential controversies. This strategic reorientation comes in the wake of evolving legal landscapes and the necessity for firms to recalibrate their approaches amidst heightened scrutiny from both regulatory bodies and the market at large.